Durynes G-I, antiproliferative polyacetylenes from Cribrochalina vasculum and their chlorinated decomposition products Authors: Lucero Martinez-Fructuoso, Susan Ensel, Rhone K. Akee, Brian D. Peyser, John R. Britt, Jason R. Evans, Barry R. O'Keefe, Tanja Grkovic Published: 2026 ABSTRACT Bioassay-guided fractionation of the organic solvent extract of sponge Cribrochalina vasculum yielded three new linear asymmetric polyacetylenes, namely durynes G-I (3–5). Their structures were elucidated by combined spectroscopic and spectrometric techniques and the absolute configuration of the C-3 stereogenic center was determined via modified Mosher's ester methodology. The compounds were found to be unstable upon prolonged exposure to deuterated chloroform and gradually converted to multi-chlorinated analogues, whose structures were fully elucidated, and the mechanism of formation was proposed. In the NCI-60 cancer cell cytotoxicity panel, the new natural products showed potent antiproliferative activity with GI50 values in low micromolar ranges. Analogues with the addition of chlorine to the central olefin showed reduced cytotoxic activity, while the chlorination of the olefin of the alkenyl carbinol group was shown to diminish the activity of the scaffold. Introduction Polyacetylenes are a diverse class of natural products with reported antifungal, antimicrobial, and antiviral activities, as well as cytotoxicity against numerous cancer cell lines.1,2 More than 300 polyacetylene marine natural products have been isolated from sponges, and in particular from the genera Petrosia, Xestospongia, Strongylophora, Haliclona, Reniera, and Callyspongia.1 Structurally, this class is characterized by the presence of one or several sp-hybridized triple bonds, which often occur along unbranched aliphatic skeletons, typically made up of 20 to 40 carbons atoms, containing one or more olefin, alcohol, ketone, carboxylic acid, and nitrile group substitutions.3,4 Often, an alkenyl carbinol structural motif is present, the position and configuration of which has been shown to be a crucial pharmacophore for the cytotoxicity of the group.4,5 Chemical biology studies on polyacetylenes isolated from marine sponges have proposed the mechanism of anti-cancer activity as inhibition of DNA replication,6,7 together with the inhibition of cell proliferation through the modulation of proteins related to the cell cycle and the induction of apoptosis.8–12 In a screening campaign aimed at the identification of cytotoxic activity of natural product samples using the NCI human tumor cell lines screen (NCI-60),13 an extract of the sponge Cribrochalina vasculum (NSC # C30509) displayed potent and selective antiproliferative activity and was selected for bioassay-guided purification work. Herein, we describe the isolation, structural elucidation, and NCI-60 activity of a series of linear asymmetric polyacetylenes named durynes G-I (3–5) as well as their decomposition products which resulted from NMR data acquisition and sample handling in deuterated chloroform. Experimental General experimental procedures Optical rotations were recorded on a Rudolph Research Analytical Autopol IV polarimeter using a 0.25 dm cell in the solvent indicated. NMR spectra were recorded at 25 °C on a 600 MHz Bruker Avance III HD spectrometer, equipped with a triple resonance 5 mm CPP TCI cryo-probe, operating at a frequency of 600.0 MHz for the 1H nucleus and 150.9 MHz for the 13C nucleus. All 2D NMR experiments were acquired with non-uniform sampling (NUS) set to 40% (for 1H–1H detected experiments) or 35% (for 1H–13C detected experiments). The 1H and 13C NMR chemical shifts were referenced to the solvent peak for CDCl3 at δH 7.26 δC 77.16. NMR FID processing and data interpretation was done using MestReNova software, version 14.2. High resolution mass spectra were recorded on an Agilent 6545 Accurate-Mass Q-TOF LC/MS system (1290 Infinity II) and 6230 Accurate-Mass TOF LC/MS system (1290 Infinity II) equipped with a dual AJS ESI source. HPLC purification was performed with either a Gilson HPLC purification system equipped with a GX-281 liquid handler, a 322-binary pump, and a 172-photodiode array detector or a Waters Prep LC system, equipped with a Delta 600 pump and a 996-photodiode array detector. All solvents used for chromatography, UV, and MS were HPLC grade, and the H2O was Millipore Milli-Q PF filtered. Sponge material The sponge C. vasculum was collected by SCUBA at a depth of 9 m in December 2008 in Florida, U.S. under contract through sea samples for the National Cancer Institute. The specimen was taxonomically identified by Dr Michelle Kelly-Borges, and a voucher specimen (0M9G1420) was deposited at the Smithsonian Institution in Suitland MD. The sponge (148.85 g) was extracted in water, followed by a CH3OH/CH2Cl2 overnight soak according to the National Cancer Institute's standard marine extraction procedure detailed in McCloud14 to give the organic solvent extract C30509 (3.86 g) used for this study. Extraction and isolation A portion of the organic extract (1.0 g) was pre-fractionated on C8 SPE (4 × 250 mg) eluting sequentially as follows: H2O/CH3OH (19 : 1) to yield 197.8 mg of fraction 1, H2O/CH3OH (4 : 1) to yield 72.9 mg of fraction 2, H2O/CH3OH (3 : 2) to yield 23.9 mg of fraction 3, H2O/CH3OH (2 : 3) to yield 16.4 mg of fraction 4, H2O/CH3OH (1 : 4) to yield 33.4 mg of fraction 5, CH3OH to yield 135.5 mg of fraction 6, and CH3OH/CH3CN (1 : 1) to yield 185.4 mg of fraction 7. Fraction 6 was purified by C18 HPLC using an Phenomenex Onyx Monolithic C18 [5 µm, 100 × 10 mm] semi-preparative column at a flow rate of 3.8 mL min−1 eluting with a steep gradient from H2O [0.1% formic acid (FA)]/CH3CN [0.1% FA] (7 : 3) to CH3CN [0.1% FA] over 9 min. Collection was performed in 30 s increments. Fractions 17–22 were further purified using a Phenomenex Luna C18 [10 µm, 250 × 21.2 mm] preparative column at a flow rate of 15 mL min−1 eluting with a steep gradient from H2O [0.1% FA]/CH3CN [0.1% FA] (4 : 1) to CH3CN [0.1% FA] over 30 min. The conditions were isocratic at H2O [0.1% FA]/CH3CN [0.1% FA] (4 : 1) for 5 min followed by a gradient from H2O [0.1% FA]/CH3CN [0.1% FA] (4 : 1) to CH3CN [0.1% FA] over 25 min, followed by an isocratic hold at CH3CN [0.1% FA] over 20 min. Collection was performed in 1 min increments. Fraction 24 yielded duryne (1) 1.3 mg (0.13% crude organic extract weight), fraction 27 yielded duryne B (2) 0.9 mg (0.09% crude organic extract weight) and fraction 41 yielded duryne H (4) 2.9 mg (0.29% crude organic extract weight). Fractions 29 and 30 enriched in 5 were further purified using a Phenomenex Onyx Monolithic C18 [5 µm, 100 × 10 mm] column at a flow rate of 10 mL min−1 eluting with a steep gradient from H2O [0.1% FA]/CH3CN [0.1% FA] (3 : 2) to CH3CN [0.1% FA] over 30 min. The conditions were isocratic at H2O [0.1% FA]/CH3CN [0.1% FA] (3 : 2) for 5 min followed by a gradient from H2O [0.1% FA]/CH3CN [0.1% FA] (3 : 2) to CH3CN [0.1% FA] over 25 min, followed by an isocratic hold at CH3CN [0.1% FA] over 20 min, with collections performed in 1 min increments. Fraction 11 yielded duryne I (5) 2.4 mg (0.24% crude organic extract weight). Fractions 32 and 33 enriched in 3 were further purified using the above method to yield duryne G (3) 2.0 mg (0.20% crude organic extract weight). Duryne (1): colorless oil; [α]D −7.20 (c 0.15, CHCl3); NMR spectroscopic data (SI Fig. S1 and S2) in agreement to those previously reported;15 HRESIMS m/z 463.3553 [M + Na]+ (calcd for C30H48O2Na, 463.3552). Duryne B (2): colorless oil; [α]D −9.33 (c 0.15, CHCl3); NMR spectroscopic data (SI Fig. S3 and S4) in agreement to those previously reported;15 HRESIMS m/z 491.3863 [M + Na]+ (calcd for C32H52O2Na, 491.3865). Duryne G (3): colorless oil; [α]D −9.30 (c 0.09, CHCl3); UV (MeOH) λmax (log ε) 190 (4.56) nm; IR (film) 3311 (broad), 2925, 2854, 2112, 1716, 1458, 1019, 634 cm−1; 1H NMR (600 MHz, CDCl3) and 13C NMR (151 MHz, CDCl3) data see Table 1 and SI Fig. S6–S10; HRESIMS m/z 425.3789 [M + H]+ (calcd for C30H49O, 425.3783). Table 1 1H (600 MHz) and 13C NMR (151 MHz) spectroscopic data for durynes G-I (3–5) measured in chloroform-d345Position δ C, type δ H mult (J in Hz)Position δ C, type δ H mult (J in Hz)Position δ C, type δ H mult (J in Hz)174.6, CH2.57, d (2.2)173.9, CH2.57, d (2.2)174.7, CH2.57, d (2.2)283.5, C—283.5, C—283.3, C—363.0, CH4.84, ddd (6.1, 2.2, 1.5)362.0, CH4.84, ddd (6.1, 2.2, 1.5)362.8, CH4.84, ddd (6.2, 2.2, 1.1)4128.5, CH5.60, ddt (15.3, 6.1, 1.5)4127.7, CH5.60, ddt (15.2, 6.1, 1.5)4128.4, CH5.63, ddt (15.0, 6.2, 1.5)5134.9, CH5.92 dtd (15.3, 6.8, 1.3)5134.1, CH5.92, dtd (15.2, 6.8, 1.4)5134.9, CH5.92, dtd (15.0, 6.8, 1.3)632.2, CH22.07, q (7.2)631.4, CH22.07, m632.2, CH22.07, m7–13, 18–2532.1–28.9, CH21.44–1.31, m7–13, 18–2731.9–27.2, CH21.44–1.31, m728.96, CH21.40, m14, 1727.4, CH22.02, m14, 1726.6, CH22.01, m8–23, 27–3731.9, CH21.33–1.21, m15, 16130.1, CH5.35, m15, 16129.3, CH5.35, m24, 2637.3, CH21.27, m1.07, m2630.5, CH22.33, qd (7.5, 1.5)2829.5, CH22.33, qd (7.5, 1.7)2532.8, CH21.36, m27146.5, CH6.00, dtd (10.9, 7.5, 0.9)29145.7, CH5.99, dtd (10.8, 7.5, 0.9)3732.0, CH21.25, m28108.1, CH5.45, ddt (10.9, 2.3, 1.4)30107.1, CH5.45, ddt (10.8, 2.7, 1.5)3822.8, CH21.30, m2980.7, C—3180.7, C—3914.1, CH30.89, t (7.0)3081.7, CH3.06, d (2.3)3281.0, CH3.06, d (2.6)4019.9, CH30.84, d (6.6) 1H (600 MHz) and 13C NMR (151 MHz) spectroscopic data for durynes G-I (3–5) measured in chloroform-d Duryne H (4): colorless oil; [α]D −7.02 (c 0.11, CHCl3); UV (MeOH) λmax (log ε) 193 (4.64) nm; IR (film) 3312 (broad), 2924, 2853, 2115, 1713, 1464, 633 cm−1; 1H NMR (600 MHz, CDCl3) and 13C NMR (151 MHz, CDCl3) data see Table 1 and SI Fig. S12–S16; HRESIMS m/z 475.3906 [M + Na]+ (calcd for C32H52ONa, 475.3916). Duryne I (5): colorless oil; [α]D +6.35 (c 0.06, CHCl3); UV (MeOH) λmax (log ε) 192 (4.73) nm; IR (film) 3311 (broad), 2922, 2852, 2122, 1464, 1011, 966, 653 cm−1; 1H NMR (600 MHz, CDCl3) and 13C NMR (151 MHz, CDCl3) data see Table 1 and SI Fig. S18–S22; HRESIMS m/z 595.5804 [M + Na]+ (calcd for C40H76ONa, 595.5794). Preparation of 15,16-dichloroduryne analogues Duryne (1) and duryne B (2) (0.5 mg each) were dissolved in chloroform-d (190 µL). These solutions were then transferred into two clean NMR tubes for overnight NMR data acquisition after which the samples were dried at room temperature under a stream of N2. The vials were stored at 4 °C and eight days later, the process was repeated over three additional days until all of the starting material was consumed. 15,16-Dichloroduryne (6): colorless oil; 1H NMR (600 MHz, CDCl3) δ 5.92 (dt, J = 15.3, 6.2 Hz, 2H, H-5, H-26), 5.61 (ddd, J = 15.3, 6.2, 1.5 Hz, 2H, H-4, H-27), 4.84 (ddd, J = 6.2, 2.3, 1.6 Hz, 2H, H-3, H-28), 4.04 (dt, J = 11.2, 2.6, 2H, H-15, H-16), 2.57 (d, J = 2.2 Hz, 2H, H-1, H-30), 2.07 (m, 4H, H-6, H-25), 1.90 (m, 2H, H-14, H-17), 1.78 (m, 2H, H-14, H-17), 1.39 (m, 4H, H-7, H-24), 1.43–1.23 (m, 20H, H-8–H-12, H-19–H-23); 13C NMR (151 MHz, CDCl3) δ 134.7 (C-5, C-26), 128.5 (C-4, C-27), 83.5 (C-2, C-29), 74.1 (C-1, C-30), 65.8 (C-15, C-16), 63.0 (C-3, C-28), 34.6 (C-14, C-17), 32.07 (C-6, C-25), 29.6–28.95 (C-8–C-12, C-19–C-23), 26.86 (C-7, C-24). (Fig. S27–S31); HRESIMS m/z 533.2923 [M + Na]+ (calcd for C30H48Cl2NaO2, 533.2925). 15,16-Dichloroduryne B (7): colorless oil; 1H NMR (600 MHz, CDCl3) δ 5.92 (dt, J = 14.3, 6.6 Hz, 2H, H-5, H-26), 5.61 (ddd, J = 14.3, 6.2, 1.6 Hz, 2H, H-4, H-27), 4.84 (br d, J = 6.2 Hz, 2H, H-3, H-28), 4.04 (dd, J = 8.6, 3.4 Hz, 2H, H-15, H-16), 2.56 (d, J = 2.2 Hz, 2H, H-1, H-30), 2.07 (q, J = 7.2 Hz, 4H, H-6, H-25), 1.91 (ddt, J = 14.6, 9.9, 5.0 Hz, 4H, H-14, H-17), 1.80 (m, 2H, H-14, H-17), 1.39 (m, 4H, H-7, H-24), 1.32–1.20 (m, 20H, H-8–12, H-19–23) (Fig. S33); HRESIMS m/z 561.3232 [M + Na]+ (calcd for C32H52Cl2NaO2, 561.3237). Preparation of 4,5,15,16,28,29-hexachloroduryne B Oxone (3.3 mg, 10.7 µmol) and NaCl (0.7 mg, 11.9 µmol) were stirred at 0 °C for 30 min in the dark. A solution of duryne B (2) (0.5 mg, 1.1 µmol) was dissolved in 100 µL of CH2Cl2 and 10 µL of headspace from the chlorine-generating reaction was added to the reaction vial and stirred for 5 minutes. The reaction product 8 was dried at room temperature under a stream of N2. 4,5,15,16,28,29-Hexachloroduryne B (8): colorless oil; 1H NMR (600 MHz, CDCl3) δ 5.08 (m, 2H, H-3, H-28), 4.01 (m, 2H, H-4, H-27), 4.04 (m, 4H, H-3, H-28, H-15, H-16), 2.55 (s, 2H, H-1, H-30), 1.90 (m, 2H, H-7, H-24), 1.79 (m, 4H, H-6, H-25), 1.78 (m, 2H, H-14, H-17), 1.62–1.22 (m, 24H, H-8–13, H-18–23); 13C NMR (151 MHz, CDCl3) δ 75.67 (C-1, C-30), 74.78 (C-2, C-29), 68.44 (C-4, C-27), 65.71 (C-5, C-26), 65.70 (C1-15, C-16), 64.16 (C-3, C-28), 35.01 (C-14, C-17) 34.84 (C-6, C-25), 34.57 (C-7, C-24), 29.89–25.15 (C-8–13, C-18–23) (Fig. S35 and S36); HRESIMS m/z 701.1996 [M + Na]+ (calcd for C32H52Cl6NaO2, 701.1991). Preparation of (R)- and (S)-MTPA ester derivatives of compounds 3–5 Compounds 3 (0.7 mg, 1.65 µmol), 4 (0.7 mg, 1.54 µmol), 5 (0.7 mg, 1.22 µmol) were dissolved in CH3OH (250 µL) and the solution of each compound was transferred into six clean NMR tubes (each compound was prepared in duplicate) and dried under vacuum for 72 h. Pyridine-d5 (500 µL) and (S)- or (R)-α-methoxy-α- (trifluoromethyl)phenylacetyl chloride [(S)- or (R)-MTPA-Cl] (100 µL, 520 µmol) were added, purged with nitrogen, and the progress of the reaction was monitored by 1H NMR. Following two hours of reaction time, reaction crudes were purified by HPLC using a Phenomenex Onyx Monolithic C18 [5 µm, 100 × 10 mm] column at a flow rate of 10 mL min−1 eluting with a steep gradient from water H2O [0.1% FA]/CH3CN [0.1% FA] (2 : 3) to CH3CN [0.1% FA] over 60 min. Fraction 33 and 36 yielded (S)- and (R)- duryne G (3) 0.4 mg each. Fraction 34 and 36 yielded (S)- and (R)- duryne H (4) 0.5 mg each. Fraction 31 and 23 yielded (S)- and (R)- duryne I (5) 0.5 each. The 1H NMR spectra of the products were recorded (SI Fig. S23–S25). Results and discussion The organic solvent extract of the sponge C. vasculum was prefractionated on C8 solid-phase extraction (SPE) media using a stepwise elution gradient from H2O to CH3OH/CH3CN (1 : 1).16 The NCI-60 active fraction six that eluted with CH3OH was further separated by preparative HPLC to yield compounds 1–5 as colorless oils. Known polyacetylenes (−)-(3R,4E,15Z,26E,28R)-duryne (1) and (−)-(3R,4E,15Z,28E,30R)-duryne B (2) were identified by comparison of their 1H and 13C NMR spectra and chiroptical data with published literature values.15 Compound 3 was isolated as an optically clear oil ([α]D −9.30, c 0.09, CHCl3) with a molecular formula C30H48O, determined from HRESIMS measurements (m/z 425.3789 [M + H]+ Δmmu 1.4). The 1H and 13C NMR spectra in chloroform-d (Table 1) showed 11 well resolved resonances comprised of two sp-hybridized and six sp2-hybridized methines, one sp3-hybridized oxymethine, three well resolved sp3-hybridized methylenes, and a methylene envelope integrating for 30 1H resonances. Comparison of the 1 and 2D NMR data of 3 with that of 1 and 2 identified a common terminal alkenyl carbinol moiety on one side of the molecule represented by NMR shifts for a terminal acetylene at C-1 (δH = 2.57, δC = 74.58), a quaternary carbon at C-2 (δC = 83.5), an oxygenated methine resonance at C-3 (δH = 4.84, δC = 63.0), and two mutually coupled olefin resonances at C-4 and C-5 (δH = 5.92, δC = 134.9 and δH = 5.60, δC = 128.5 respectively). The other terminus in the structure of 3 was capped with an enyne group characterized by an acetylenic methine at C-30 (δH = 3.06, δC = 85.7) showing 1H–13C HMBC correlations to a quaternary carbon at C-29 (δC = 80.7) and a pair of olefinic resonances at C-27 and C-28 (δH = 6.00, δC = 146.5 and δH = 5.45, δC = 108.1 respectively) (Fig. 1A). The only other well resolved resonance was an additional olefin multiplet (δH = 3.06, δC = 85.7) which showed 1H–13C HMBC correlations to an overlapped alkyl region (δH = 1.44–1.31, δC = 32.1–28.9). The location of the isolated olefin within the methylene envelope was assigned through the fragmentation pattern observed in the HRESIMS/MS spectrum (Fig. 1B), where the molecule underwent dehydration and then allylic rupture17 at positions C-14 and C-17 which resulted in the formation of two fragment ions at m/z 177 and m/z 229 respectively, confirming the placement of the double bond between C-15 and C-16. Vicinal coupling constants of the double bonds at C-4 and C-5 and C-26 and C-27 were well resolved and established the geometry to be E (J4,5 = 15.3 Hz) and Z (J27,28 = 10.9 Hz) respectively. Double bond configuration at C-15 and C-16 was determined to be Z through the comparison of the allylic methylene carbon chemical shifts at C-14 and C-17 (δC = 27.4) with those reported in the literature.18 The absolute configuration of the secondary alcohol at C-3 was determined to be R through the application of the modified Mosher's method19 (Fig. 1C) to complete the configurational assignment of 3 to be 3R,4E,15Z,27Z. Compound 3 is a rare report of a marine polyacetylene natural product with a combination of terminal ethynyl vinyl carbinol and enyne groups. Based on the co-occurrence with 1, 2, and 3 in the same organism, the new natural product 3 was given a trivial name duryne G. (A) Crucial 1H–13C HMBC correlations used to elucidate the structure of duryne G (3). (B) Production spectrum of compound 3 ([M + H]+m/z 425.3774) at collision energy setting of 30 eV under positive ion ESI mode. (C) Modified Mosher's ester analysis for 3 with Δδ (δS − δR) values shown. Duryne H (4) had a molecular formula of C32H52O determined by HRESIMS measurements (m/z 475.3906 [M + Na]+, Δmmu −2.1), and 1 and 2D NMR data closely resembling that of 3 (Table 1). With the only significant difference in the NMR spectra of 3 and 4 being the integration of the methylene envelope and supported by the C2H4 difference in the calculated molecular formulae, we concluded that compound 4 was an elongated lipid chain congener of 3. The mass spectral fragmentation pattern of 4 showed equivalent fragment ions resulting from the allylic rupture17 at m/z 177 and m/z 229, (SI Fig. S11), positioning the central olefin between C-15 and C-16 and securing the planar structure of 4. The double bond geometries, established via vicinal coupling constant analysis and allylic carbon 13C NMR shifts in compound 4 were consistent with that of 3 (Table 1), and the absolute configuration of the secondary alcohol at C-3 was determined to be R through the application of the modified Mosher's method (SI Fig. S24) to complete the configurational assignment of duryne H (4) to be (3R,4E,15Z,29Z). Duryne I (5) was isolated as an optically clear oil ([α]D +6.4, c 0.06, CHCl3) with a molecular formula C40H76O, determined from HRESIMS measurements (m/z 595.5804 [M + Na]+ Δmmu 1.7). The 1 and 2D NMR spectra of 5 showed significantly less sp- and sp2-hybridized structural features compared to 1–4. Compound 5 showed resonances associated with an alkenyl carbinol moiety represented by a terminal acetylene at C-1 (δH = 2.57, δC = 74.7), a quaternary carbon at C-2 (δC = 83.5), an oxygenated methine resonance at C-3 (δH = 4.84, δC = 62.8), and two mutually coupled olefin resonances at C-4 and C-5 (δH = 5.92, δC = 134.9 and δH = 5.63, δC = 128.5 respectively). A terminal sp3-hybridized triplet methyl resonance (δH = 0.89, δC = 14.2) capped the other end of the molecule, with an additional methyl doublet (δH = 0.84, δC = 19.9) present in the NMR spectra of 5 showing 1H–13C HMBC correlations to an overlapped alkyl region. Methyl substitution at C-31 in the aliphatic chain was assigned through the fragmentation pattern observed in the HRESIMS/MS spectrum (SI Fig. S17). The geometry of the olefin in compound 5 at positions C-4 and C-5 was determined to be E from the magnitude of the coupling constant (J4,5 = 15.0 Hz), and the absolute configuration of the C-3 stereogenic center was found to be S through the modified Mosher's ester method (SI Fig. S25). Configuration of the C-31 stereogenic center was not experimentally determined. During compound isolation and structural determination work, compounds 1–4 were found to be unstable to prolonged exposure to chloroform-d and a gradual mass increase corresponding to an addition of two chlorine atoms to the molecule (m/z 561.3237) was observed. Full NMR characterization of the dichlorinated adducts of 1 and 2, 15,16-dichloroduryne (6) and 15,16-dichloroduryne B (7), showed the reaction product corresponded to chlorination of the central cis-olefin (Fig. 2B). Over time and repeated NMR measurements for compound 7, the chlorination reaction proceeded to occur on all the sp2 hybridized positions to give a hexachlorinated adduct at m/z 701.1991, and a full NMR structural elucidation established the structure to be 4,5,15,16,28,29-hexachloroduryne B (8) (Fig. 2C). While there are literature reports of polyacetylenes being unstable, for example dideoxypetrosynols A–D were found to be liable at room temperature,20 this is a first report of an artifactual addition of chlorine on the double bond for this scaffold. Due to the addition of chlorine to the vinylic portion present at C-15 and C-16, it was hypothesized that the artifacts arose from slow decomposition of chloroform and generation of chlorine gas.21,22 To confirm, 2 was reacted with chlorine gas generated in situ by oxone/NaCl in DCM/H2O according to the procedure by Ren and Tong.23 After 20 min, the addition of six chlorine atoms was confirmed by both MS and 1H NMR with the spectra of the product identical to compound 8. Interestingly, routine NMR analysis of compound 5 did not show formation of chlorinated adducts, indicating that polyacetylenes with a central cis-olefin and two alkenyl carbinol structural motifs are most liable to react with small quantities of chlorine gas generated in the NMR tube. Change in 1H NMR signals (δH = 6.5–4.5 ppm) observed during formation of chlorinated adducts. (A) Duryne B starting material (2); (B) 15,16-dichloroduryne B (6), and (C) 4,5,15,16,28,29-hexachloroduryne B (8). Compounds 1–8 were tested in the NCI-60 human tumor cell line cytotoxicity screen,13,24 with the results presented in Table 2. The antiproliferative activity of the isolated natural products ranged from 0.42 to >10 µM, with the symmetric the di-alkenyl carbinol structures 1 and 2 being the most potent and the asymmetric analogues 3 and 4 containing the alkenyl carbinol and enyne groups almost an order of magnitude less active. Moreover, increasing the aliphatic chain length on the enyne group-containing part of the molecule from eight carbons in 3 to ten carbons in 4 had a detrimental effect on the activity. Compound 5 with one alkenyl carbinol moiety and no additional polyene groups was the least active of the isolated natural products. Chlorination had an effect on the cytotoxicity of the duryne scaffold, with dichlorinated compounds 6 and 7 showing diminished activity compared to their parent compounds 1 and 2 respectively, and the hexachloro analogue 8 inactive at the highest concentration tested (10 µM). Compounds 1–6 showed a remarkable selectivity against the melanoma LOX-IMVI cell line (Table 2 and Fig. 3) with 1, 2, 3, and 6 comparable to that of the doxorubicin control. Table 2Antiproliferative activity of compounds 1–8. The NCI-60 GI50 value represents the average calculated across all sixty cell lines. Doxorubicin (NSC 123127) was used as a positive control in the experimentCompoundNCI-60 GI50 (µM)LOX-IMVI GI50 (µM)10.580.0320.420.0331.280.0544.780.1657.240.2162.750.0472.5715.58>10>10Doxorubicin0.130.05 Antiproliferative activity of compounds 1–8. The NCI-60 GI50 value represents the average calculated across all sixty cell lines. Doxorubicin (NSC 123127) was used as a positive control in the experiment NCI-60 dose response data of compounds 1–6. (A) All cells plot with the GI50 crossover shown with a dashed line. Colors represent 9 different human tumor tissue types: leukemia (red), melanoma (orange), non-small-cell lung carcinoma (blue), and cancers of the brain(grey), ovary (purple), breast (pink), colon (green), kidney (olive/yellow), and prostate (turquoise). (B) Mean GI50 plot, with the vertical line representing the average GI50 value across all 60 cell lines, bars to the left depicting resistant cell lines, and the bars to the right depicting sensitive cell lines. The black rectangle highlights the LOX-IMVI cell line. Conclusions Isolation of three new polyacetylenes from C. vasculum, durynes G-I (3–5), from an effort to obtain compounds with significant cytotoxic activity, provides an interesting example of the challenges encountered during the purification and isolation of natural products. We demonstrated the reactivity of the isolated compounds during routine exposure to chloroform-d for NMR structural elucidation work and solved the structures of their multi-chlorinated adducts. Isolation procedure artefacts are common in natural product isolation efforts but are often overlooked and unreported. However, their accurate annotation can add value to understanding the structural diversity, reactivity, and biological activity of natural products.25,26 Here, by purifying and structurally and biologically characterizing a series of chlorine adducts on the alkene groups of the duryne scaffold, we confirmed the importance of the alkenyl carbinol group for the activity of the polyacetylene natural products. Conflicts of interest The authors declare no conflicts of interest. Supplementary Material